EP 1725221 A2 20061129 - USE OF MRP4-INHIBITORS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
Title (en)
USE OF MRP4-INHIBITORS FOR THE TREATMENT AND/OR PROPHYLAXIS OF CARDIOVASCULAR DISEASES
Title (de)
VERWENDUNG VON MRP4-INHIBITOREN ZUR BEHANDLUNG UND/ODER PROPHYLAXE KARDIOVASKULÄRER ERKRANKUNGEN
Title (fr)
UTILISATION D'INHIBITEURS DE MRP4 POUR ASSURER LE TRAITEMENT ET/OU LA PROPHYLAXIE DE MALADIES CARDIO-VASCULAIRES
Publication
Application
Priority
- EP 2004012554 W 20041105
- DE 10352511 A 20031107
Abstract (en)
[origin: WO2005044244A2] The invention relates to the use of inhibitors of the multidrug resistance protein 4 (MRP4) in thrombocytes for the treatment and/or prophylaxis of cardiovascular diseases.
IPC 8 full level
A61K 31/00 (2006.01); A61K 31/192 (2006.01); A61K 31/405 (2006.01); A61K 31/47 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); G01N 33/50 (2006.01)
CPC (source: EP US)
A61K 31/00 (2013.01 - EP US); A61K 31/192 (2013.01 - EP US); A61K 31/405 (2013.01 - EP US); A61K 31/47 (2013.01 - EP US); A61K 31/517 (2013.01 - EP US); A61K 31/519 (2013.01 - EP US); A61P 9/00 (2017.12 - EP)
Citation (search report)
See references of WO 2005044244A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LU MC NL PL PT RO SE SI SK TR
Designated extension state (EPC)
AL HR LT LV MK YU
DOCDB simple family (publication)
WO 2005044244 A2 20050519; WO 2005044244 A3 20061005; DE 10352511 A1 20050616; EP 1725221 A2 20061129; US 2007212366 A1 20070913
DOCDB simple family (application)
EP 2004012554 W 20041105; DE 10352511 A 20031107; EP 04797661 A 20041105; US 57845204 A 20041105